Mortality benefit of angiotensin-converting enzyme inhibitors after cardiac events in patients with end-stage renal disease
- 1 September 2002
- journal article
- Published by SAGE Publications in Journal of the Renin-Angiotensin-Aldosterone System
- Vol. 3 (3), 188-191
- https://doi.org/10.3317/jraas.2002.040
Abstract
Hypothesis/IntroductionKeywords
This publication has 18 references indexed in Scilit:
- Cardiovascular disease and the kidneyPostgraduate Medicine, 2002
- AbstractCardiovascular Radiation Medicine, 2002
- AbstractCardiovascular Radiation Medicine, 2002
- Lisinopril therapy for hemodialysis hypertension: Hemodynamic and endocrine responsesAmerican Journal of Kidney Diseases, 2001
- Determinants of mortality after myocardial infarction in patients with advanced renal dysfunctionAmerican Journal of Kidney Diseases, 2001
- Are all angiotensin-converting enzyme inhibitors interchangeable?Journal of the American College of Cardiology, 2001
- Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patientsThe Lancet, 2000
- Poor Long-Term Survival after Acute Myocardial Infarction among Patients on Long-Term DialysisNew England Journal of Medicine, 1998
- Current efforts toward implementation of an urban health strategy: The Henry Ford Health SystemJournal of Urban Health, 1998
- Significance of left ventricular hypertrophy in cardiovascular morbidity and mortalityCardiovascular Drugs and Therapy, 1994